×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Worldwide schedules comment Share

Please give us your feedback after the live

Fill the survey →


Since the advent of TEVAR, we have witnessed endovascular repair being applied to treat increasingly complicated disease states in challenging aortic anatomies. Thoracic endografting provides a therapeutic option to an increasing number of patients who are not good candidates for open repair or who prefer a minimally invasive approach.
 
However, despite recent advancements, TEVAR is not free from complications, and challenges with bird-beaking and windsocking continue to be a problem, especially in the aortic arch, with deployment mechanisms where the proximal end opens while the distal end remains constrained. 
 
Discover in this webinar how to overcome these challenges and the novel features that the new GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System introduces.

Program

18:00 Introduction and presentation of learning objectives of the session - Prof. G. Torsello
 
18:10 TEVAR device selection and case planning in consideration of disease and anatomy - Dr R. Heijmen
 
18:20 Introducing the new GORE® TAG® Conformable Thoracic Endoprosthesis with Active Control System - Prof. G Torsello
 
18:30 Live-in-Box Presentation: TEVAR in short and angulated neck case example
  • Patient description and introduction of the case - Dr M. Austermann
  • Panel Discussion
19:00 Live-in-Box Presentation: TEVAR in challenging anatomies key learnings from other clinical cases
 
19:20 Closing Remarks

 

Objectives

  • Gain knowledge on endovascular treatment of thoracic aortic aneurysms
  • TEVAR devices selection and best strategies for optimal patient's outcomes
  • Understand proper patient selection criteria, sizing and implantation techniques for the GORE® TAG® Conformable stent graft with ACTIVE CONTROL system
  • TEVAR Case planning consideration and oversizing options in consideration of patient anatomy and indications (trauma, dissection)
  • Precise Placement in the proximal neck and proximal to the celiac trunk, angulation control in the proximal neck and overlapping zones
  • Provide platform for discussion with experts, about patients’ outcomes and population treated with TEVAR

Target audience

  • Endovascular specialists (vascular surgeons, interventional radiologists, interventional angiologists, interventional cardiologists and cardiothoracic surgeons)
Shooting date : 2018-03-19
Last update : 2018-03-20
Robin Heijmen
Nieuwegein, Netherlands
2 comments
Join the Discussion
  • Nikolaos S. Which are the advantages of the Gore thoracic device apart from the active meccanism in comparison with the well established long term results of the Zenith TX and also the newer Zenith Alpha thoracic stent graft? Nikolaos Sch.

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • William O. Greetings from Detroit.
      Could you discuss guideline for spinal drainage?

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      Suggestions

      Monday, November 9th 2020 from 05:30pm to 06:30pm (GMT+1)
      Honolulu : Monday, November 9th 2020 from 06:30am to 07:30am (GMT+1)
      San Francisco : Monday, November 9th 2020 from 08:30am to 09:30am (GMT+1)
      New York : Monday, November 9th 2020 from 11:30am to 12:30pm (GMT+1)
      Buenos Aires : Monday, November 9th 2020 from 01:30pm to 02:30pm (GMT+1)
      London / Dublin : Monday, November 9th 2020 from 04:30pm to 05:30pm (GMT+1)
      Paris / Berlin : Monday, November 9th 2020 from 05:30pm to 06:30pm (GMT+1)
      Istanbul : Monday, November 9th 2020 from 06:30pm to 07:30pm (GMT+1)
      Moscou / Dubaï : Monday, November 9th 2020 from 08:30pm to 09:30pm (GMT+1)
      Bangkok : Monday, November 9th 2020 from 11:30pm to 12:30am (GMT+1)
      Shanghai : Tuesday, November 10th 2020 from 12:30am to 01:30am (GMT+1)
      Tokyo : Tuesday, November 10th 2020 from 01:30am to 02:30am (GMT+1)
      Sydney : Tuesday, November 10th 2020 from 02:30am to 03:30am (GMT+1)
      Wellington : Tuesday, November 10th 2020 from 04:30am to 05:30am (GMT+1)

      Percutaneous Endovascular AAA Repair

      Daily practice and clinical evidence

      Share
      Thursday, February 28th 2019 from 11:30am to 01pm (GMT+1)
      Honolulu : Thursday, February 28th 2019 from 12:30am to 02am (GMT+1)
      San Francisco : Thursday, February 28th 2019 from 02:30am to 04am (GMT+1)
      New York : Thursday, February 28th 2019 from 05:30am to 07am (GMT+1)
      Buenos Aires : Thursday, February 28th 2019 from 07:30am to 09am (GMT+1)
      London / Dublin : Thursday, February 28th 2019 from 10:30am to 12pm (GMT+1)
      Paris / Berlin : Thursday, February 28th 2019 from 11:30am to 01pm (GMT+1)
      Istanbul : Thursday, February 28th 2019 from 12:30pm to 02pm (GMT+1)
      Moscou / Dubaï : Thursday, February 28th 2019 from 02:30pm to 04pm (GMT+1)
      Bangkok : Thursday, February 28th 2019 from 05:30pm to 07pm (GMT+1)
      Shanghai : Thursday, February 28th 2019 from 06:30pm to 08pm (GMT+1)
      Tokyo : Thursday, February 28th 2019 from 07:30pm to 09pm (GMT+1)
      Sydney : Thursday, February 28th 2019 from 08:30pm to 10pm (GMT+1)
      Wellington : Thursday, February 28th 2019 from 10:30pm to 12am (GMT+1)

      Introducing innovative solutions for the treatment of visceral arteries in complex BEVAR and FEVAR

      Best clinical practice for achieving perfusion of visceral arteries

      Share
      Wednesday, November 10th 2021 from 12pm to 01:30pm (GMT+1)
      Honolulu : Wednesday, November 10th 2021 from 01am to 02:30am (GMT+1)
      San Francisco : Wednesday, November 10th 2021 from 03am to 04:30am (GMT+1)
      New York : Wednesday, November 10th 2021 from 06am to 07:30am (GMT+1)
      Buenos Aires : Wednesday, November 10th 2021 from 08am to 09:30am (GMT+1)
      London / Dublin : Wednesday, November 10th 2021 from 11am to 12:30pm (GMT+1)
      Paris / Berlin : Wednesday, November 10th 2021 from 12pm to 01:30pm (GMT+1)
      Istanbul : Wednesday, November 10th 2021 from 01pm to 02:30pm (GMT+1)
      Moscou / Dubaï : Wednesday, November 10th 2021 from 03pm to 04:30pm (GMT+1)
      Bangkok : Wednesday, November 10th 2021 from 06pm to 07:30pm (GMT+1)
      Shanghai : Wednesday, November 10th 2021 from 07pm to 08:30pm (GMT+1)
      Tokyo : Wednesday, November 10th 2021 from 08pm to 09:30pm (GMT+1)
      Sydney : Wednesday, November 10th 2021 from 09pm to 10:30pm (GMT+1)
      Wellington : Wednesday, November 10th 2021 from 11pm to 12:30am (GMT+1)

      The New Frontier of Iliac Stenting

      Learning the Fundamentals of a Transradial Approach

      Share
      Scroll Up